CARsgen Therapeutics Holdings Ltd banner

CARsgen Therapeutics Holdings Ltd
HKEX:2171

Watchlist Manager
CARsgen Therapeutics Holdings Ltd Logo
CARsgen Therapeutics Holdings Ltd
HKEX:2171
Watchlist
Price: 18.67 HKD 8.23%
Market Cap: HK$10.6B

Wall Street
Price Targets

Price Targets Summary
CARsgen Therapeutics Holdings Ltd

Wall Street analysts forecast CARsgen Therapeutics Holdings Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CARsgen Therapeutics Holdings Ltd is 20.4 HKD with a low forecast of 14.44 HKD and a high forecast of 26.99 HKD.

Lowest
Price Target
14.44 HKD
23% Downside
Average
Price Target
20.4 HKD
9% Upside
Highest
Price Target
26.99 HKD
45% Upside
CARsgen Therapeutics Holdings Ltd Competitors:
Price Targets
VRNS
Varonis Systems Inc
61% Upside

Revenue
Forecast

N/A
Past Growth
305% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
305% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

The compound annual growth rate of CARsgen Therapeutics Holdings Ltd's revenue for the next 2 years is 305%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CARsgen Therapeutics Holdings Ltd's stock price target?
Price Target
20.4 HKD

According to Wall Street analysts, the average 1-year price target for CARsgen Therapeutics Holdings Ltd is 20.4 HKD with a low forecast of 14.44 HKD and a high forecast of 26.99 HKD.

What is CARsgen Therapeutics Holdings Ltd's Revenue forecast?
Projected CAGR
305%

The compound annual growth rate of CARsgen Therapeutics Holdings Ltd's revenue for the next 2 years is 305%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett